Dr. Jacob Sands discusses the significance of the FDA approval of Datroway for the treatment of patients with locally ...

For patients with bladder cancer undergoing radical cystectomy, or the surgical removal of the bladder, one possible option ...

SAR446523, an investigational antibody targeting GPRC5D, received FDA orphan drug status and is in phase 1 trials for ...

A resilience program for young people with advanced cancer helped patients cope early on and led to a better quality of life ...

Writing helped me focus on gratitude and healing after my colon cancer diagnosis, transforming the act into a powerful ...

Unlike most GI cancers, GIST starts in supportive stromal tissue, not surface cells, and is classified as a sarcoma, says Dr.

As July concludes, new treatments offer advances across kidney and bladder cancer, with breakthroughs in personalized vaccines and non-surgical therapies.

Six-time cancer survivor Staci Kirk urges patients to trust their bodies and speak up to ensure their needs are understood ...

Jaypirca led to better response rates than Imbruvica in some previously treated patients with chronic lymphocytic leukemia or ...

The FDA awarded orphan drug designation to VT3989 for mesothelioma, supporting the experimental cancer treatment’s ...

AbbVie submitted a supplemental new drug application for Venclexta plus Calquence treatment in previously untreated chronic ...

As July concludes, momentum in lung cancer research continues to build, marked by FDA decisions, trial progress, and ...